FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely sodium valproate 300 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Sodium valproate 600 mg gastro-resistant oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Sodium valproate 600 mg gastro-resistant oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Ascorbic acid 1 g and zinc citrate 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Ascorbic acid 1 g and zinc citrate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Ascorbic acid 1 g and zinc citrate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin calcium) 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely abacavir (as abacavir hydrochloride) 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 43.75 milligram and entacapone 200 milligram and levodopa 175 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 43.75 milligram and entacapone 200 milligram and levodopa 175 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 43.75 milligram and entacapone 200 milligram and levodopa 175 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 43.75 milligram and entacapone 200 milligram and levodopa 175 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Ibuprofen 150 mg and paracetamol 500 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Ibuprofen 150 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Ibuprofen 150 mg and paracetamol 500 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely dexketoprofen 25 milligram and tramadol hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely dexketoprofen 25 milligram and tramadol hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely dexketoprofen 25 milligram and tramadol hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Zonisamide 100 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Zonisamide 100 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely zonisamide 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely zonisamide 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely zonisamide 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely zonisamide 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Paroxetine (as paroxetine hydrochloride) 30 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Paroxetine (as paroxetine hydrochloride) 30 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 25 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely hydrochlorothiazide 25 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Calcium gluconate 200 mg and colecalciferol 20 microgram and nicotinic acid 20 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Paroxetine (as paroxetine hydrochloride) 40 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Paroxetine (as paroxetine hydrochloride) 40 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely indapamide 2.5 milligram and perindopril tosilate 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely indapamide 1.25 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Indapamide 625 microgram and perindopril tosilate 2.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and perindopril tosilate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Amlodipine (as amlodipine besilate) 10 mg and perindopril tosilate 5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Amlodipine (as amlodipine besilate) 5 mg and perindopril tosilate 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely perindopril (as perindopril arginine) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely perindopril (as perindopril arginine) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ivacaftor 150 milligram and tezacaftor 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely ivacaftor 150 milligram and tezacaftor 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely ivacaftor 150 milligram and tezacaftor 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely ivacaftor 75 milligram and tezacaftor 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some

Start Previous Page 86 of 87 End

This concept is not in any reference sets

Back to Start